Treatment of the causative embolic lesion and lower risk of stroke recurrence |
Lower risk of intracranial hemorrhage (avoidance of hyperperfusion, acute antiplatelet agents) |
Improvement of cerebral perfusion with potential attenuation of infarct progression |
Lower risk of iatrogenic artery-to-artery embolization during stent deployment |
Contribution to spontaneous intracranial clot lysis |
No risk of in-stent thrombosis |
|
Avoids delays in intracranial recanalization (if stent placement before thrombectomy) |
|
Lower risk of procedural bradycardia and hypotension from carotid baroreceptor activation with stent deployment |